Key Drivers
- Strong Liquidity
- Improving Profitability
- Rich Valuation
AIAI Summary
BLFS has meaningfully shifted from a speculative CGT story to a credible, cash-rich operator after delivering 25% revenue growth, 64% gross margin and positive earnings, but with no guidance, thin operating margins and negative free cash flow, the stock is now a repeat-execution bet rather than a de-risked re-rating.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Liquidity
- •Improving Profitability
- •Rich Valuation
BLFS has a very strong, lightly levered balance sheet and improved quarterly profitability, but weak efficiency, a long loss history, and a rich tangible-book valuation keep the risk/reward mixed.
Price Behavior
Key Price Behavior Insights:
- •Rebound off support
- •Higher-lows pattern
- •Near resistance test
BLFS is constructive after rebounding from mid-June lows, but it remains capped near $28.5-$28.7 and needs to hold the $25-$25.5 support zone to keep the bullish trend intact.
Sharp rebound from the mid-20s shows strong short-term volatility after the late-June dip
Sentiment & News
Similar Companies in Healthcare
Other companies in the same sector with AI ratings